Takeda Pharmaceutical Co Ltd - Company Profile

Powered by

All the data and insights you need on Takeda Pharmaceutical Co Ltd in one report.

  • Save hours of research time and resources with
    our up-to-date Takeda Pharmaceutical Co Ltd Strategy Report

  • Understand Takeda Pharmaceutical Co Ltd position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Takeda Pharmaceutical Co Ltd: Overview

Takeda Pharmaceutical Co Ltd (Takeda) is a research-based pharmaceutical company, which focuses on the discovery, development, manufacturing, marketing, commercialization, import and export of drugs. It provides treatment for inflammatory bowel disease, acid-related diseases, motility disorders and liver diseases; hemophilia and hereditary bleeding disorders; primary immunodeficiency and multifocal motor neuropathy; major depressive disorder and attention-deficit hyperactivity disorder; and its cancer treatment encompasses multiple myeloma, mantle cell lymphoma, non-small cell lung cancer and chronic myeloid leukemia. It markets products directly and through a network of wholesale distributors, retail chains and other purchasing groups worldwide. Takeda has partnership with academic institutions, small biotech, and large pharmaceutical companies. It has presence in the Americas, Europe, and Asia, among others. Takeda is headquartered in Tokyo, Japan.

Gain a 360-degree view of Takeda Pharmaceutical Co Ltd and make more informed decisions for your business Gain a 360-degree view of Takeda Pharmaceutical Co Ltd and make more informed decisions for your business Find out more
Headquarters Japan

Address 4f, 2-1-1, Nihombashihon-Cho, Chuo-Ku, Tokyo, 103-8668


Telephone 81 3 32782111

No of Employees 49,095

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange 4502 (TYO)

Revenue (2023) $29.8B 12.8% (2023 vs 2022)

EPS XYZ

Net Income (2023) XYZ 37.8% (2023 vs 2022)

Market Cap* $44.5B

Net Profit Margin (2023) XYZ 22.0% (2023 vs 2022)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Takeda Pharmaceutical Co Ltd premium industry data and analytics

3,300+

Clinical Trials

Determine Takeda Pharmaceutical Co Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

1,200+

Catalyst Calendar

Proactively evaluate Takeda Pharmaceutical Co Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

1,100+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Takeda Pharmaceutical Co Ltd’s relevant decision makers and contact details.

800+

Pipeline Drugs

Identify which of Takeda Pharmaceutical Co Ltd’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

450+

Marketed Drugs

Understand Takeda Pharmaceutical Co Ltd’s commercialized product portfolio to stay one step ahead of the market.

430+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

110+

Sales & Consensus Forecasts

Understand the current and future drug revenue for Takeda Pharmaceutical Co Ltd and assess market opportunity for new entrants with patient population 8-year forecasts.

100+

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

3

IT Services Contracts

Improve competitive bidding with insights into all publicly disclosed IT services contracts for Takeda Pharmaceutical Co Ltd (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Takeda Pharmaceutical Co Ltd’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
Therapy Areas: Actos
Oncology Blopress
Gastroenterology Takepron
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Takeda Pharmaceutical Co Ltd portfolio and identify potential areas for collaboration Understand Takeda Pharmaceutical Co Ltd portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2023 Regulatory Approval In November, the company secured an approval from the European Commission for TAKHZYRO (lanadelumab) for the routine prevention of recurrent attacks of Hereditary Angioedema (HAE) in patients aged 2 years and older.
2023 Regulatory Approval In November, the company secured approval from the US Food and Drug Administration for its Fruzaqla (fruquintinib) for patients with metastatic colorectal cancer (mCRC) who have undergone previous treatment.
2023 Contracts/Agreements In October, the company announced an alliance with the Mark Foundation for Cancer Research to accelerate the discovery and development of novel treatments for cancer.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Takeda Pharmaceutical Co Ltd Pfizer Inc F. Hoffmann-La Roche Ltd Merck & Co Inc AbbVie Inc
Headquarters Japan United States of America Switzerland United States of America United States of America
City Chuo-Ku New York Basel Kenilworth North Chicago
State/Province Tokyo New York - New Jersey Illinois
No. of Employees 49,095 83,000 103,613 69,000 50,000
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Christophe Weber Director; President; Chief Executive Officer Executive Board 2015 57
Costa Saroukos Director; Chief Financial Officer Executive Board 2018 52
Takako Ohyabu Chief Global Corporate Affairs Officer Senior Management 2019 44
Gabriele Ricci Chief Data and Technology Officer Senior Management 2022 45
Mwana Lugogo Chief Ethics & Compliance Officer Senior Management 2019 53
Non Dignissim Eros Proin vel Convallis 2023 XY
Non Dignissim Eros Proin vel Convallis 2023 XY
Non Dignissim Eros Proin vel Convallis 2023 XY
Gain insight into Takeda Pharmaceutical Co Ltd key executives to enhance your sales strategy Gain insight into Takeda Pharmaceutical Co Ltd key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward